ArticleBMC medical imaging2026
Construction and validation of high altitude pulmonary edema prediction models based on deep learning and quantitative analysis of X-ray images.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To address the clinical challenges of interpreting subtle radiographic signs of high altitude pulmonary edema and the limited accessibility of invasive EVLWI monitoring, this study validates a deep learning-based framework for noninvasive, quantitative prediction of EVLWI from chest X-ray images. Utilizing a Vision Transformer architecture adapted for medical image regression, the model integrates lung field segmentation, hybrid local–global feature extraction, and relative position encoding to enhance sensitivity to early pathological changes. Trained and evaluated on data from a high altitude medical center in Qinghai (n = 1,280), the model achieves a Pearson correlation coefficient of 0.921 and an RMSE of 1.324 mL/m². External validation on an independent cohort from Tibet (n = 1,646) confirms robust generalizability, with high accuracy maintained in subclinical stages (R²=0.832). This study demonstrates the clinical feasibility of translating imaging-based deep learning into a noninvasive, interpretable tool for early warning and decision support in high altitude pulmonary edema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.